AUA2022: Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach episode artwork

EPISODE · Jun 15, 2022 · 1H 54M

AUA2022: Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach

from AUAUniversity · host American Urological Association

Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach (2022) CME Available: https://auau.auanet.org/node/36020 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Identify low, intermediate and high risk non-muscle invasive bladder cancer (NMIBC) 2. Recommend treatment for NMIBC based on risk stratification. 3. Identify bacillus Calmette-Guérin (BCG) unresponsive NMIBC and novel immune-based strategies and intravesical therapies. 4. Manage invasive bladder cancer including surgery, neoadjuvant and adjuvant chemotherapy and bladder preservation strategies in patients with muscle invasive bladder cancer. This will include chemotherapy indications and the role of immunotherapy in the management. 5. Manage upper tract tumors, both low grade and high grade, including renal preservation when appropriate, neoadjuvant therapy when indicated and surgical management strategies.

Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach (2022) CME Available: https://auau.auanet.org/node/36020 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Identify low, intermediate and high risk non-muscle invasive bladder cancer (NMIBC) 2. Recommend treatment for NMIBC based on risk stratification. 3. Identify bacillus Calmette-Guérin (BCG) unresponsive NMIBC and novel immune-based strategies and intravesical therapies. 4. Manage invasive bladder cancer including surgery, neoadjuvant and adjuvant chemotherapy and bladder preservation strategies in patients with muscle invasive bladder cancer. This will include chemotherapy indications and the role of immunotherapy in the management. 5. Manage upper tract tumors, both low grade and high grade, including renal preservation when appropriate, neoadjuvant therapy when indicated and surgical management strategies.

NOW PLAYING

AUA2022: Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach

0:00 1:54:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AUAUniversity?

This episode is 1 hour and 54 minutes long.

When was this AUAUniversity episode published?

This episode was published on June 15, 2022.

What is this episode about?

Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach (2022) CME Available: https://auau.auanet.org/node/36020 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Identify low, intermediate and...

Can I download this AUAUniversity episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!